Recombinant Human Epithelial Derived Neutrophil Activating Protein 78, 8-78a.a./CXCL5
RP01873
Product Specifications
| Product Type | Recombinant protein |
|---|---|
| Applications | Bioactivity, Endotoxin |
| Source | E. coli. |
| UniProt No. | P42830 |
| Purity | > 95 % by SDS-PAGE and HPLC analyses. |
| Bioactivity | Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human peripheral blood neutrophils is in a concentration of 10.0-100.0 ng/ml. |
| Endotoxin | Less than 1 EU/ug of rHuENA-78, 8 – 78 a.a./CXCL5 as determined by LAL method. |
| Molecular Weight | Approximately 7.8 kDa, a single non-glycosylated polypeptide chain containing 71 amino acids. |
| Formulation | Lyophilized from a 0.2 μm filtered concentrated solution in 2 × PBS, pH 7.4. |
| Alternative Names | ENA-78, 8-78 a.a./CXCL5, ENA-78, SCYB5, Human |
| Storage | -20C |
| Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 C. Further dilutions should be made in appropriate buffered solutions. |
| Research Area | Immunology |